Genotypic resistance mutations to antiretroviral drugs in HIV-1 B and non-B subtypes from Cuba

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 10, Issue 3, 2001, Pages 174-180

  Ruibal Brunet, Ignacio J ^a   Cuevas, M Teresa ^b   Díaz Torres, Héctor ^a   Villahermosa, M Luisa ^b   Noa Romero, Enrique ^a   Vázquez De Parga, Elena ^b   Blanco De Armas, Madelin ^a   Pérez Álvarez, Lucía ^b  

^a AIDS Research Laboratory   (Cuba)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

AIDS; Antiretroviral drugs; Cuba; Drug resistance; HIV

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; DELAVIRDINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LAMIVUDINE; NEVIRAPINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

DISEASE CONTROL; DRUG RESISTANCE; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS;

ARTICLE; CONTROLLED STUDY; CUBA; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PREVALENCE; VIRUS LOAD; VIRUS MUTATION; VIRUS RESISTANCE; VIRUS TYPING;

CUBA;

EID: 0034771264     PISSN: 10204989     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1020-49892001000900005     Document Type: Article

References (28)

1. Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy
2. Natural occurrence of drug resistance mutations in the reverse transcriptase of human immunodeficiency virus type 1 isolates
3. pol gene quasispecies of human immunodeficiency virus: Mutations associated with drug resistance in virus from patients undergoing no drug therapy
4. Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management
5. Antiviral drug resistance: Issues and challenges
6. Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure
7. Drug-resistance genotyping in HIV-1 therapy: The VI-RADAPT randomised controlled trial
8. Increase in the frequency of mutation at codon 215 associated with zidovudine resistance in HIV-1-infected antiviral-naive patients from 1989 to 1996
9. Evaluation of mixtures of wild-type HIV-1 and HIV-1 with resistance point mutations against reverse transcriptase inhibitors
10. Envelope V3 region sequences of Cuba HIV-1 isolates
11. Isolates from four different HIV-1 type 1 clades circulating in Cuba identified by DNA sequence of the C2-V3 region
12. pol gene diversity of five human immunodeficiency virus type 1 subtypes: Evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D
13. Drug susceptibility of subtype A, B, C, D and E HIV-1 primary isolates
14. Prevention 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
15. New method for the extraction of RNA and DNA from cerebrospinal fluid for use in the polymerase chain reaction assay
16. Analysis of HIV type 1 protease and reverse transcriptase sequences from Venezuela for drug resistance associated mutations and subtype classification: A UNAIDS study
17. Clinical correlates and molecular basis of HIV drug resistance
18. High prevalence of MDR mutation in a UK HIV/AIDS patient population
19. Gods and monsters: Are we breeding a superbug?
20. Single and multidrug resistance mutations to reverse transcriptase and protease inhibitors: Human immunodeficiency virus type 1-infected patients from two geographical areas in Spain
21. 3′-Azido-3′-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitors
22. Prevalence of genotyping resistance among antiretroviral drug-naive HIV-1 infected patients in Belgium
23. Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom
24. HIV protease and reverse transcriptase variation and therapy outcome in antiretroviral-naive individuals from a large North American cohort
25. Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy
26. High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Cote d'Ivoire
27. Improved conditions for extraction and amplification of human immunodeficiency virus type 1 from plasma samples with low viral load